Identification of Diarylurea Inhibitors of the Cardiac-Specific Kinase TNNI3K by Designing Selectivity Against VEGFR2, p38α, and B-Raf
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of Diarylurea Inhibitors of the Cardiac-Specific Kinase TNNI3K by Designing Selectivity Against VEGFR2, p38α, and B-Raf
Authors
Keywords
-
Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 21, Pages 15651-15670
Publisher
American Chemical Society (ACS)
Online
2021-10-27
DOI
10.1021/acs.jmedchem.1c00700
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Insights into 4-Anilinoquinazolines as Inhibitors of Cardiac Troponin I–Interacting Kinase (TNNi3K)
- (2020) Christopher R. M. Asquith et al. MOLECULES
- Discovery of novel TNNI3K inhibitor suppresses pyroptosis and apoptosis in murine myocardial infarction injury
- (2020) Haiying Pang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 3D-QSAR Assisted Design of Novel 7-Deazapurine Derivatives as TNNI3K Kinase Inhibitors using Molecular Docking and Molecular Dynamics Simulation
- (2019) Pavithra K. Balasubramaniana et al. Letters in Drug Design & Discovery
- 4,6-Diaminopyrimidines as Highly Preferred Troponin I-Interacting Kinase (TNNI3K) Inhibitors
- (2018) Joanne Philp et al. JOURNAL OF MEDICINAL CHEMISTRY
- GSK114: A selective inhibitor for elucidating the biological role of TNNI3K
- (2016) Brian G. Lawhorn et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Substituent Effects on Drug–Receptor H-bond Interactions: Correlations Useful for the Design of Kinase Inhibitors
- (2016) Brian G. Lawhorn et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, antiangiogenesis evaluation and molecular docking studies of 1-aryl-3-[(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas: Discovery of a new substitution pattern for type II VEGFR-2 Tyr kinase inhibitors
- (2015) Vera A. Machado et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Identification of Purines and 7-Deazapurines as Potent and Selective Type I Inhibitors of Troponin I-Interacting Kinase (TNNI3K)
- (2015) Brian G. Lawhorn et al. JOURNAL OF MEDICINAL CHEMISTRY
- TNNI3K in cardiovascular disease and prospects for therapy
- (2015) Annalisa Milano et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- The drug–target residence time model: a 10-year retrospective
- (2015) Robert A. Copeland NATURE REVIEWS DRUG DISCOVERY
- Troponin I-Interacting Protein Kinase
- (2014) Hind Lal et al. CIRCULATION JOURNAL
- Sorafenib Cardiotoxicity Increases Mortality After Myocardial Infarction
- (2014) Jason M. Duran et al. CIRCULATION RESEARCH
- Inhibition of the Cardiomyocyte-Specific Troponin I–Interacting Kinase Limits Oxidative Stress, Injury, and Adverse Remodeling due to Ischemic Heart Disease
- (2014) Dennis M. Abraham et al. CIRCULATION RESEARCH
- Ins and Outs of Kinase DFG Motifs
- (2013) Daniel K. Treiber et al. CHEMISTRY & BIOLOGY
- Explaining why Gleevec is a specific and potent inhibitor of Abl kinase
- (2013) Y.-L. Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of the Cardiomyocyte-Specific Kinase TNNI3K Limits Oxidative Stress, Injury, and Adverse Remodeling in the Ischemic Heart
- (2013) R. J. Vagnozzi et al. Science Translational Medicine
- The discovery of potent and selective 4-aminothienopyridines as B-Raf kinase inhibitors
- (2012) Jun Tang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Overexpression of TNNI3K, a cardiac-specific MAPKKK, promotes cardiac dysfunction
- (2012) Hao Tang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors
- (2012) M. McTigue et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adenovirus-mediated overexpression of cardiac troponin I-interacting kinase promotes cardiomyocyte hypertrophy
- (2011) Lin Wang et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Role of p38 inhibition in cardiac ischemia/reperfusion injury
- (2011) Sarawut Kumphune et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Analysis of Imatinib and Sorafenib Binding to p38α Compared with c-Abl and b-Raf Provides Structural Insights for Understanding the Selectivity of Inhibitors Targeting the DFG-Out Form of Protein Kinases
- (2010) Haridasan V. Namboodiri et al. BIOCHEMISTRY
- Tnni3k Modifies Disease Progression in Murine Models of Cardiomyopathy
- (2009) Ferrin C. Wheeler et al. PLoS Genetics
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started